Pacific Edge cuts losses by $4.7m on US growth

Pacific Edge cuts losses by $4.7m on US growth
Total lab throughput for tests dipped 6% compared to the prior year.
Brent Melville
Cancer diagnostics firm Pacific Edge has slowed its cash burn on the strength of key wins in its core US market, trimming net losses after tax by a quarter, or $4.7 million, to $14.2m for the year to March.That came off a more than doubling in revenue to $10.4m from a comparable $5.2m in 2020, with operating revenue from test sales at $7.7m, driven by inroads into the commercialisation of its Cxbladder product into international markets.Chief executive David Darling said the result had been achieved despite headwinds created by covid particular...

More Markets

NZ sharemarket down as retail spending stalls in new data
Markets Market Close

NZ sharemarket down as retail spending stalls in new data

April figures from Stats NZ show spending in the retail industry that month was flat.

Tom Raynel 14 May 2025
How Sharesies is providing ‘patient’ capital for listeds
Finance

How Sharesies is providing ‘patient’ capital for listeds

The online platform is being tapped for bookbuilds and dividend reinvestment plans.

NZX rallies 0.87% as tariff uncertainty eases
Markets Market Close

NZX rallies 0.87% as tariff uncertainty eases

Skellerup bounced 4.11% as investors digested easing tariffs. 

Gregor Thompson 13 May 2025
Flick not profitable before $70m sale to Meridian
Markets

Flick not profitable before $70m sale to Meridian

After eight years of trying in electricity retailing, Z throws in the towel.

Ian Llewellyn 13 May 2025